Founded in 2014 by Stéphane Miras, LC Fitness, headquartered in Chessy (77), specializes in the development and operation of gyms under the Fitness Park franchise in France and Spain. The Group is expanding in two ways: by opening new gyms and by acquiring new clubs in areas with strong development potential.

Based in Livry-Gargan and Puteaux, the new clubs strengthen the Group’s territorial coverage. Thanks to their ideal locations and brand-new infrastructures, the two gyms should have around 10,000 subscribers within 3 years.

With these two new acquisitions, LC Fitness now heads 25 Fitness Park clubs, including 16 in France. It also runs the Fitness Park master franchise in Spain, with 24 franchisees.

Founded in 2014 by Stéphane Miras, LC Fitness, headquartered in Chessy (77), is specialized in the development and operation of gyms under the Fitness Park franchise in France and Spain. The Group has developed along two axes: the opening of new gyms and the acquisition of new clubs in areas with strong development potential.

To date, LC Fitness operates 23 Fitness Park clubs, including 14 in France and 10 in Spain, with a total of 69,000 subscribers. It also runs the Fitness Park master franchise in Spain, with 24 franchisees.

In a steadily growing market in the wake of the health crisis, LC Fitness intends to capitalize on its expertise to accelerate its development and territorial coverage.

The 5 health clubs, already operating under the Fitness Park franchise and currently owned by the Ladjal Group, are geographically complementary, as they are located in the Paris region, with nearly 30,000 active customers by the end of 2024. The deal is financed by €14 million in debt, provided by Société Générale, Banque Populaire Rives de Paris, CIC and BPI France.

Created in 2020 by Dr Pierre Durand and Éric Le Bihan, Imagerie.fr is an operator of medical imaging and teleradiology centers. Its aim is to make radiology examinations accessible to as many people as possible, especially in high-tension areas or medical deserts, at prices affordable to all.

The Group has developed an efficient model using digital levers across the whole care pathway, as well as a secure proprietary technological platform integrating artificial intelligence and blockchain. Examinations are done on site, but results are interpreted remotely. Headquartered in Grenoble, the group operates 12 centers across France, staffed by more than 80 employees, including 12 radiologists.

Oradianse is also a network of local radiology centers. Its aim is to meet the growing needs of French patients, by combining on-site and remote activities to maintain a regional radiology offer. Headquartered in Bordeaux, Oradianse brings together over a hundred medical practices throughout France, more than 330 radiologists and over 2,600,000 patient files processed annually.

To step up its growth, Imagerie.fr was looking for a partner and appointed Largillière Finance. Thanks to its in-depth knowledge of the healthcare sector, Largillière Finance is now involved in its 3rd transaction in this sector, following its support over the last 12 months for BELILAB Laboratories in their merger with BIOPATH Laboratoires, and for the XLabs laboratory network in the setting up of a structured financing package with CIC. For Imagerie.fr, Largillière Finance quickly identified and successfully completed the transaction with Oradianse, which thus strengthened its territorial coverage, particularly in eastern France.

Founded in 1985 by Michel Bendahan, XLabs, headquartered in Cholet (49), is an independent inter-regional network of medical biology laboratories based in the Pays de la Loire and Nouvelle-Aquitaine regions. Historically, the network has developed through external growth, followed by the opening of new sites.

Today, XLabs brings together 10 sampling sites, including a technical platform in Cholet, and relies on an expert team of over 150 employees, including 12 medical biologists, processing 750 dossiers per day (excluding Covid). XLabs has ISO 9001 certification and COFRAC accreditation, which certify the reliability and quality of all analyses performed in the laboratories. It is the only multi-site laboratory with this accreditation in the Pays de la Loire region.

In a market that has grown steadily since the health crisis, XLabs intends to capitalize on its expertise and experienced teams to accelerate its development and consolidate its position as a benchmark in the West of France, as well as in the rest of France.

Consequently, the financing will be used to open new sites and selectively take advantage of external growth opportunities. Through this geographic expansion, XLabs aims to offer a local network for independent, quality and innovative medical biology for the health and well-being of patients.

BELILAB, which dates back to 1945, operates four laboratories and a technical platform in Béthune, in the Pas-de-Calais region – an arrangement that enables it to perform analyses locally within a short timeframe and that will be maintained in the new group.

BIOPATH Laboratories is the leading independent medical biology group in the Hauts-de-France region with 46 sites organized around 10 technical and emergency platforms, 2 AMP* centers, 46 medical biologists who receive 8,000 patients/day excluding COVID.

By joining BIOPATH Laboratoires, BELILAB will keep its structures and teams, and will become part of a group recognized for its innovative equipment, its ability to organize and adapt, particularly during the COVID crisis, and its proximity to patients and healthcare partners.

The combination of BELILAB’s sites with those of BIOPATH Laboratoires will enable the new entity to strengthen its geographical coverage and reinforce its position as the leading independent medical biology company in the Hauts-de-France region, where the healthcare sector is strongly consolidating.

The sale process was led by the teams of Largillière Finance, under an exclusive mandate from BELILAB’s shareholders. At the end of a very competitive process, which attracted strong interest from several national and regional players, it was finally BIOPATH Laboratoires that convinced BELILAB’s partners.

Founded in 2006 in Lille by Emilie Croxo and Grégory Bouillon, Adenior is a network of specialist personal services franchises with a strong foothold in the Hauts-de-France region. Initially focused on home help for dependent individuals, the network has become a specialist offering multiple services (childcare, household cleaning services, etc.). Adenior has 24 branches and reports overall turnover exceeding €10 million. In 2020 it was ranked the best multiple home services brand in France by the magazine Capital.

Against a backdrop of sustained and steady growth during the pandemic, the managing shareholders of Adenior asked Largillière Finance to locate a strategic partner.

The efficient process put in place by Largillière Finance pinpointed several high-quality offers, and Groupe Destia was chosen by Adenior’s managing shareholders.

The operation involved a 100% sale of Adenior, allowing Groupe Destia to consolidate its presence in Hauts-de-France. Emilie Croxo and Grégory Bouillon join Groupe Destia and retain operational leadership of Adenior.

About Adenior

Founded in 2006, Adenior is a multi-services home help brand specialising in services for elderly and dependent people, household cleaning services and childcare. Adenior has 24 branches primarily located in Hauts-de-France and Ile-de-France, approximately 3,000 beneficiaries and around 700 employees. In 2020, the network reported turnover of over €10 million.

About Destia

Groupe Destia was formed following the merger of Groupe Sous Mon Toit and Avidom in 2015. It specialises in assisting vulnerable people at home, childcare and household cleaning services. The group has over one hundred locations across France. It has over 14,000 beneficiaries and more than 5,500 employees. It is supported by several investment funds, including Azulis Capital.

Stakeholders:

with two family group owner-managers and a family office

The luxury perfume brand Les Eaux Primordiales, founded by Arnaud Poulain in 2015, has found its way onto the shelves of many affluent stores worldwide (Harrods, Selfridges, Galeries Lafayette, Liberty…) in less than five years.

Established in a sector with very high added-value, Les Eaux Primordiales has continued to grow and open prestigious accounts worldwide.

Eager to have the resources to achieve its ambitions and loyal to its regional roots, Arnaud Poulain has welcomed two major shareholders from Hauts de France: Francis-Charles Pollet, founder of the Promod group, Thierry Letartre, owner of Laboratoires Anios, as well as Edouard Herbo, founder of the family office Keepers.

The funding brought by these new shareholders will help support the company’s impressive growth.

About Les Eaux Primordiales (www.leseauxprimordiales.com)

The luxury perfume brand Les Eaux Primordiales, founded in 2015 by Arnaud Poulain, has its roots in Hauts de France. Its products are sold in over 70 luxury points of sale across France and worldwide.

Stakeholders:

Verso Healthcare, a leading French finance lease company and subsidiary of the insurance company MACSF, acquires Nova Lease Solutions, a fellow expert in the medical and IT sectors.

Founded in 1990, Nova Lease Solutions is a long-standing French finance lease company. The Paris-based company specialises in finance leases for professional equipment in the medical and IT sectors.  Owned by its managers and the entrepreneur fund Pléiade Investissement, the company notably acquired TechnoFinance in 2018, which specialises in financing medical equipment. In 2020, Nova Lease Solutions owned machinery worth approximately €150 million, with over 1,700 customers.

With this acquisition, Verso Healthcare reaches the symbolic figure of €200 million in turnover, with €450 million of assets under management. Nova Lease Solutions’ significant range of machinery and its expertise in medical and technological assets will reinforce Verso Healthcare’s expertise. Francis Enguehard and Frédéric Sig, managers of Nova Lease Solutions, will continue business development within the Group managed by Christophe Sicot.

About Nova Lease Solutions (www.nova-lease.com)

Founded in 1990, Nova Lease Solutions is a long-standing French finance lease company. The company specialises in leasing with no option to buy for professional equipment in the medical and IT sectors. The company has been supported by the family office Pléiade Investissement since 2018.

About Verso Healthcare (www.verso.healthcare)

Verso Healthcare is a French group and a European market leader specialising in financing medical equipment and the associated services. Since 2019, the Group has been a subsidiary of the insurance company MACSF, which finances its numerous external growth projects.

Stakeholders:

Mr. and Mrs. Bellavoine, founders and leaders of Laboratoire Bellavoine, have entrusted Largillière Finance with the mandate to sell their company to Corus.

Created nearly 30 years ago, Laboratoire Bellavoine has become the leading manufacturer of all types of dental prostheses in Picardy. It owns a modern technical center of 700 m² in Saint-Quentin (52) and it is also located in Amiens (80) and Reims (51).

Through this acquisition, Corus is setting up in the region and continues its geographical coverage. The Bellavoine Laboratory will be one of Corus’ regional hubs in France. He will remain under the operational management of Mr. and Mrs. Bellavoine who join Corus.

About Laboratoire Bellavoine (www.bellavoine.siteconseil.fr)

Created in 1988 by Gérard and Dorothée Bellavoine, Laboratoire Bellavoine is one of the leading manufacturers of dental prosthesis in the Hauts-de-France.

The laboratory has a modern technical area of ​​700 m² located at its headquarters in Saint-Quentin (52). It is also located in Amiens (80) and Reims (51).

The Bellavoine Laboratory employs nearly 50 people and has an aggregate turnover of more than € 4 million.

About Corus (www.corusdental.com)

Corus is the leading European group for dental restoration. Born in 2015, Corus aims to unite dental prosthetic laboratories at European level to better meet the challenges of the sector.

Corus is supported by key shareholders including CM-CIC Investissement.

Stakeholders List :